Recombinant multi-species TRIM63 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRIM63 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the RING zinc finger protein family found in striated muscle and iris. The product of this gene is an E3 ubiquitin ligase that localizes to the Z-line and M-line lattices of myofibrils. This protein plays an important role in the atrophy of skeletal and cardiac muscle and is required for the degradation of myosin heavy chain proteins, myosin light chain, myosin binding protein, and for muscle-type creatine kinase. [provided by RefSeq, Feb 2012]
The Alternative Names of target: E3 ubiquitin-protein ligase TRIM63,IRF,Iris RING finger protein,MURF1,MURF2,MuRF1,MuRF1),Murf,Murf1,Muscle-specific RING finger protein 1 (MuRF-1,RF1,RING finger protein 28,RING-type E3 ubiquitin transferase TRIM63,RNF28,Rnf28,SMRZ,Striated muscle RING zinc finger protein,TRIM63,Trim63,Tripartite motif-containing protein 63

Target products collectionGo to TRIM63 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12995-Ag-1/ GM-Tg-hg-IP12995-Ag-2 Human TRIM63 protein Human
GM-Tg-rg-IP12995-Ag-1/ GM-Tg-rg-IP12995-Ag-2 Rat TRIM63 protein Rat
GM-Tg-mg-IP12995-Ag-1/ GM-Tg-mg-IP12995-Ag-2 Mouse TRIM63 protein Mouse
GM-Tg-cynog-IP12995-Ag-1/ GM-Tg-cynog-IP12995-Ag-2 Cynomolgus/Rhesus macaque TRIM63 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12995-Ag-1/ GM-Tg-felg-IP12995-Ag-2 Feline TRIM63 protein Feline
GM-Tg-cang-IP12995-Ag-1/ GM-Tg-cang-IP12995-Ag-2 Canine TRIM63 protein Canine
GM-Tg-bovg-IP12995-Ag-1/ GM-Tg-bovg-IP12995-Ag-2 Bovine TRIM63 protein Bovine
GM-Tg-equg-IP12995-Ag-1/ GM-Tg-equg-IP12995-Ag-2 Equine TRIM63 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12995-Ag-1/ GM-Tg-hg-IP12995-Ag-2; GM-Tg-rg-IP12995-Ag-1/ GM-Tg-rg-IP12995-Ag-2;
GM-Tg-mg-IP12995-Ag-1/ GM-Tg-mg-IP12995-Ag-2; GM-Tg-cynog-IP12995-Ag-1/ GM-Tg-cynog-IP12995-Ag-2;
GM-Tg-felg-IP12995-Ag-1/ GM-Tg-felg-IP12995-Ag-2; GM-Tg-cang-IP12995-Ag-1/ GM-Tg-cang-IP12995-Ag-2;
GM-Tg-bovg-IP12995-Ag-1/ GM-Tg-bovg-IP12995-Ag-2; GM-Tg-equg-IP12995-Ag-1/ GM-Tg-equg-IP12995-Ag-2
Products Name TRIM63 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TRIM63
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRIM63 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.